Detalles de la búsqueda
1.
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.
Cancer
; 2024 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38896056
2.
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry.
Haematologica
; 109(1): 115-128, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37199127
3.
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia.
Blood
; 137(14): 1879-1894, 2021 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33150388
4.
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials.
Hematol Oncol
; 39(4): 529-538, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34405901
5.
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.
Cancers (Basel)
; 15(2)2023 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36672386
6.
Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience.
Am J Hematol
; 87(6): 631-4, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22431002
7.
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group.
Dis Markers
; 2022: 3132941, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36051360
8.
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia.
Cancers (Basel)
; 14(11)2022 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35681796
9.
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study.
Blood Adv
; 6(4): 1278-1295, 2022 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34794172
10.
The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients.
Blood
; 114(20): 4369-72, 2009 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-19755674
11.
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?
Leukemia
; 35(6): 1571-1585, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33077867
12.
Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study.
Transplant Cell Ther
; 27(4): 311.e1-311.e10, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33836871
13.
Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia.
Leukemia
; 35(8): 2358-2370, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33526859
14.
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group.
Leuk Lymphoma
; 62(12): 2928-2938, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34292118
15.
Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation.
Blood
; 112(10): 4017-23, 2008 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18669875
16.
Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study.
Leuk Res
; 92: 106352, 2020 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32240863
17.
A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial.
Cancer Med
; 9(7): 2317-2329, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32022463
18.
Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry.
Leuk Lymphoma
; 60(11): 2720-2732, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31068052
19.
A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients.
Leuk Res
; 76: 1-10, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30468991
20.
Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols.
Hemasphere
; 7(1): e810, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36583094